Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,753,910
-$3,025,067 QoQ
Shares Held
803,143
-31.2% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#106
of 1,016 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $232,519,537 across 16 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,189,584 | $40,303,105 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
1,612,986 | $39,695,585 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
708,276 | $32,941,916 | |
| 4 | ALKS |
Alkermes plc.
|
560,282 | $29,358,776 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
359,721 | $17,004,011 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
846,387 | $15,201,110 | |
| 7 | VTRS |
Viatris Inc
This page
|
803,143 | $12,753,910 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
23,074 | $12,502,185 |
All Filings in VTRS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,753,910 | 803,143 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,778,977 | 1,167,948 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,451,013 | 1,160,724 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,339,103 | 1,145,364 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,282,207 | 1,151,423 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,970,694 | 1,144,741 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,510,997 | 1,165,542 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,372,536 | 893,414 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,455,385 | 889,500 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,620,630 | 889,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,834,229 | 2,293,096 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,766,654 | 889,113 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,108,750 | 812,500 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $22,217,249 | 1,996,159 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $3,769,920 | 346,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,688,145 | 346,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,695,075 | 346,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,951,485 | 346,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $24,188,286 | 1,731,445 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,488,312 | 346,228 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||